Literature DB >> 7848164

Meningococcal purpura fulminans treated with antithrombin III concentrate: what is the optimal replacement therapy?

R Cobcroft, A Henderson, C Solano, D Scott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7848164     DOI： 10.1111/j.1445-5994.1994.tb01763.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN： 0004-8291


× No keyword cloud information.
  2 in total

Review 1.  Recognition, treatment and complications of meningococcal disease.

Authors:  F A Riordan; A P Thomson
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.022

2.  Combined antithrombin and protein C supplementation in meningococcal purpura fulminans: a pharmacokinetic study.

Authors:  François Fourrier; Francis Leclerc; Karl Aidan; Ahmed Sadik; Mercé Jourdain; Antoine Tournoys; Odile Noizet
Journal:  Intensive Care Med       Date:  2003-05-22       Impact factor: 17.440
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.